Your session is about to expire
← Back to Search
Behavioural Intervention
Exercise Snacks for Type 2 Diabetes
N/A
Recruiting
Led By Jonathan Little, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have physician-diagnosed type 2 diabetes
Have had a stable medication dosage and no changes to the number of prescribed medications for at least 6 months
Must not have
Currently have diabetic ulcers, peripheral vascular disease, or diabetic neuropathy that will prevent participation in exercise
Taking insulin
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48-hour ex trial versus the 48-hour con trial
Awards & highlights
No Placebo-Only Group
Summary
"This trial will investigate how short bursts of exercise affect blood sugar levels in people with type 2 diabetes who are not very active. The study will use continuous glucose monitoring to track changes in glycemic control
Who is the study for?
This trial is for inactive individuals aged 30-75 with type 2 diabetes, a BMI of 18.5-40 kg/m2, stable medication doses for the past 6 months, and an HbA1c of ≤8.5%. They must exercise less than 150 minutes per week and can maintain their current activity level and medication during the study.
What is being tested?
The trial is testing 'exercise snacks'—short bursts of physical activity—to see how they affect blood sugar levels in people with type 2 diabetes. It's a randomized crossover trial using continuous glucose monitoring to track changes.
What are the potential side effects?
Since this intervention involves physical exercise, potential side effects may include muscle soreness, fatigue, or injury related to increased activity levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with type 2 diabetes by a doctor.
Select...
My medication and its dosage have been stable for the last 6 months.
Select...
I am between 30 and 75 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot exercise due to diabetic ulcers, peripheral vascular disease, or neuropathy.
Select...
I am currently taking insulin.
Select...
I am taking four or more medications to lower my blood sugar.
Select...
I've had a heart problem in the last 2 years that stops me from exercising.
Select...
I have a long-term muscle or bone condition that stops me from exercising.
Select...
I have not donated more than 0.5 liters of blood in the last month.
Select...
I am currently receiving dialysis.
Select...
I experience chest pain when I exert myself.
Select...
I am currently taking beta-blockers.
Select...
I am on 3 or more medications for heart disease prevention.
Select...
I have a heart or lung condition that stops me from exercising.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 48-hour ex trial versus the 48-hour con trial
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48-hour ex trial versus the 48-hour con trial
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mean 24-h glucose concentration assessed using continuous glucose monitoring
Secondary study objectives
Glycemic variability determined using continuous glucose monitoring
Time above range determined using continuous glucose monitoring
Time below range determined using continuous glucose monitoring
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise (EX): exercise snacks conditionExperimental Treatment1 Intervention
Bodyweight-style exercise snacks lasting 1-minute each performed with vigorous effort 4 times per day on two consecutive days.
Group II: Control (CON): Non-exercise conditionActive Control1 Intervention
No structured exercise on two consecutive days.
Find a Location
Who is running the clinical trial?
McMaster UniversityOTHER
918 Previous Clinical Trials
2,616,263 Total Patients Enrolled
University of British ColumbiaLead Sponsor
1,481 Previous Clinical Trials
2,494,886 Total Patients Enrolled
Jonathan Little, PhDPrincipal InvestigatorUniversity of British Columbia
6 Previous Clinical Trials
315 Total Patients Enrolled